Djibouti vs Gambia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Djibouti
82.0%
in 2025
Gambia
82.0%
in 2025
Djibouti rank
106th
Gambia rank
106th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Djibouti
- Gambia
How they compare
Djibouti currently reports 82.0% against 82.0% in Gambia, a difference of 0.0%.
Across all 18 years both countries report, Gambia has been ahead every year.
Djibouti ranks 106th and Gambia ranks 106th of 194 countries.
Gambia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Djibouti | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 55.5% | 94.6% | 39.1% | Gambia |
| 2020s | 69.7% | 79.7% | 10.0% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Djibouti or Gambia?
- Djibouti, at 82.0% against 82.0% in Gambia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Djibouti and Gambia?
- 0.0%, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and Gambia?
- 18 years are reported by both, from 2008 to 2025.
- How do Djibouti and Gambia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Djibouti ranks 106th and Gambia ranks 106th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.